Natco Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
795.60
1,060.80
1,160.20
926.90
513.30
Other Income Qtr Cr37.0029.4019.7029.0020.80
Operating Revenues Qtr758.601,031.401,140.50897.90492.50

*All values are in Cr.

Operating Expenses Qtr
490.50
573.40
612.50
558.80
386.60
Operating Profit Qtr
268.10
458.00
528.00
339.10
105.90
EBIDT Qtr Cr
305.10
487.40
547.70
368.10
126.70
Depreciation Qtr
44.20
43.60
43.50
41.00
41.50
Net Profit Qtr
212.70
369.00
420.30
275.80
62.30
Basic EPS Qtr
11.88
20.60
23.26
15.11
3.41
Open Demat Account
or Resume your Application
+91 -

personImage